Search the Newsreel

Lifecore Biomedical, Inc. Revenue Breakdown – NASDAQ:LFCR

Lifecore Biomedical, Inc. (NASDAQ: LFCR) generated $75.52 million USD in total revenue last year. Its top-performing segment, "Lifecore," contributed $128.87 million USD, an increase from $128.26 million USD in the prior year. The United States was the primary regional contributor, accounting for the same …

electroCore, Inc. Revenue Breakdown – NASDAQ:ECOR

This article provides a revenue breakdown for electroCore, Inc. (ECOR), focusing on its regional revenue contribution. For the latest disclosed data, the United States accounted for 93.89% of revenue, followed by the United Kingdom (5.29%). Information regarding business segment breakdown and future financial periods …

LFCR Q1 2026 Earnings: Deep EPS Miss Undermines Sentiment as Revenue Remains Undisclosed - Guidance Revision Trend

REC declares ₹4.25 interim dividend, sets record date for July 31

Floor & Decor Holdings, Inc. Revenue Breakdown – NYSE:FND

ECOR|electroCore, Inc.|Price:5.980|Chg%:-0.210

This article provides a comprehensive stock analysis of electroCore, Inc. (ECOR) by TradingKey, highlighting its strong fundamentals, high growth potential, and fair valuation. The company, which specializes in bioelectronic medicine, has seen impressive revenue growth and is supported by several 'Buy' ratings from analysts. …

Is Floor & Decor Holdings (FND) Undervalued After Its Recent Slide?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Floor & Decor Holdings (FND) has drawn investor attention after a recent stretch of mixed share performance, including a decline over the past …

Lifecore Biomedical Inc (LFCR) Institutional Confidence

Lifecore Biomedical Inc (LFCR) has an institutional shareholding score of 7.00, placing it 50th in the Pharmaceuticals industry. Institutional investors hold 81.48% of its shares, an increase of 8.09% quarter-over-quarter. The largest institutional holder is ETHSX, with other significant holders including Wynnefield Capital, Inc. …

Lifecore Biomedical Inc. (LFCR) Q1 2026 Earnings: EPS Misses Estimates by Wide Margin Amid Operational Challenges - Earnings Beat Streak

Lifecore Biomedical's Q1 2026 summary highlights significant revenue growth in Q3 2025, reaching $31.1 million, driven by increased demand, new business wins, and strong manufacturing growth. The company strengthened its leadership, implemented operational efficiencies, and advanced its pipeline with 11 programs targeting launches between …

How Stronger Canadian Anti‑Piracy Tools Will Impact Quebecor (TSX:QBR.A) Investors

Quebecor Welcomes Federal Court Ruling That Strengthens Site Blocking Against Evolving Piracy Threats

MONTREAL, le 23 juill. 2026 /CNW/ -- Quebecor today issued the following statement welcoming a ruling from the Federal Court of Canada that streamlines the enforcement of site-blocking orders against court-adjudicated piracy services that evade judicial oversight by migrating to new domains or rebranding: …

Floor & Decor (FND) Expected to Post Earnings on Thursday

Lifecore Biomedical (LFCR) Proxy filing Summary

Lifecore Biomedical (LFCR) has released a summary of its proxy filing for the upcoming 2024 annual meeting, to be held virtually on November 7, 2024. Shareholders will vote on director elections, auditor ratification, and executive compensation, with the board recommending approval for all proposals. …

Lifecore Biomedical (LFCR) Q1 2026 earnings summary

Lifecore Biomedical's Q1 2026 summary highlights significant revenue growth in Q3 2025, reaching $31.1 million, driven by increased demand, new business wins, and strong manufacturing growth. The company strengthened its leadership, implemented operational efficiencies, and advanced its pipeline with 11 programs targeting launches between …

Floor & Decor Holdings Inc. (FND) Stock Price | Live Quotes & Charts | NYSE

This page provides live stock quotes and charts for Floor & Decor Holdings Inc. (FND), indicating a current price of $56.81 with a 2.53% increase. It notes that there is no current analyst rating or earnings information available for FND. The article also includes …

electroCore (NASDAQ: ECOR) details 2026 virtual meeting and pay vote

electroCore, Inc. (NASDAQ: ECOR) announced details for its 2026 fully virtual annual shareholder meeting, to be held on September 8, 2026, at 9:00 a.m. Eastern Time. Shareholders will vote on electing three Class II directors, ratifying CBIZ CPAs P.C. as the independent auditor for …

What Triggered Lifecore Biomedical's Recent Stock Plunge

Lifecore Biomedical (LFCR) shares plunged over 33% after its Q4 2025 earnings report, primarily due to delayed volume expectations from key customers and a cautious outlook on new GLP-1 agreements, despite otherwise solid results. The company, a specialized CDMO in aseptic fill-finish and hyaluronic …

New Review Examines Anatomical and Methodological Differences Between Auricular and Cervical Vagus Nerve Stimulation

A new peer-reviewed article published in Frontiers in Neuroscience, authored by electroCore's Chief Medical Officer and Senior Director of Medical Affairs, compares transcutaneous auricular vagus nerve stimulation (taVNS) and transcutaneous cervical vagus nerve stimulation (tcVNS). The review highlights the anatomical and methodological differences between …

electroCore (ECOR) Publishes New Review on Vagus Nerve Stimulation Techniques

electroCore (ECOR) has published a peer-reviewed article in Frontiers in Neuroscience evaluating non-invasive vagus nerve stimulation techniques, positioning itself as a thought leader in bioelectronic medicine. The company, which has a market cap of $51.69 million and a GF Score of 72/100, shows strong …

Outer Ear vs. Neck: Review Compares Two Vagus Nerve Paths

electroCore announced the publication of a peer-reviewed review article titled "Two Paths to the Body’s Superhighway—The Auricular Branch (taVNS) and the Cervical Bundle (tcVNS)" in *Frontiers in Neuroscience*. The article, authored by electroCore's Chief Medical Officer Peter S. Staats and Senior Director of Medical …

Diversify Wealth Management LLC Purchases 22,897 Shares of Floor & Decor Holdings, Inc. $FND

Diversify Wealth Management LLC significantly increased its stake in Floor & Decor Holdings, Inc. (NYSE:FND) by 215.4% in the first quarter, acquiring an additional 22,897 shares, bringing their total to 33,527 shares valued at $1.6 million. This increase happened despite a softer Wall Street …

Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Lifecore Biomedical, Inc. (NASDAQ: LFCR) announced an inducement grant of 3,500 restricted stock units (RSUs) to a new employee. This RSU award, granted on July 13, 2026, was a material inducement for a newly hired employee to join the company and vests on the …

Why (ECOR) Price Action Is Critical for Tactical Trading

Electrocore Inc. (NASDAQ: ECOR) shows weak near and mid-term sentiment but a strong long-term outlook, with a mid-channel oscillation pattern in play. AI models have generated three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—to optimize position sizing and minimize drawdown risk. The analysis …

New Lifecore Hire Gets 3,500 Stock Units Vesting in Three Years

LFCR Q1 2026 Earnings: EPS Misses Estimates, Stock Declines - Financial Summary

Floor & Decor Holdings, Inc. Announces Second Quarter Fiscal 2026 Earnings Conference Call

Ecora Royalties final dividend due July 31 after AGM approval

Is Now An Opportune Moment To Examine Lifecore Biomedical, Inc. (NASDAQ:LFCR)?

LFCR Forecast — Price Target — Prediction for 2027

ECOR Forecast — Price Target — Prediction for 2027

LFCR Q1 2026 Earnings: Wide EPS Miss as Losses Deepen - Consensus Beat Rate

How The Ecora Royalties (LSE:ECOR) Investment Story Is Shifting With Updated Fair Value Assumptions

Does Floor & Decor (FND) Have Potential for Better Store-Level Sales And Profit Margins?

Why This Fund Made a $30 Million Bet on Floor & Decor Amid a 30% Stock Drop

Ecora Royalties PLC Announces Notification of Transactions by Directors

How The Ecora Royalties (LSE:ECOR) Story Is Shifting With A Slightly Lower Valuation Target